Related Experiment Video
Updated: Jun 11, 2025
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Outcomes in Minor Salivary Gland Tumors-A 20+ Year Tertiary-Care Center Experience
Emily S Zhang1, Samuel Doty2, Neil Woody3
1Cleveland Clinic Head and Neck Institute Cleveland USA.
Objective:
Minor salivary gland carcinomas are challenging to study due to their rarity and heterogeneity. We aim to further characterize clinical characteristics, treatment, and outcomes over 20 years within a single institution.
Study Design:
Retrospective chart review was conducted on 210 patients who received primary treatment for minor salivary gland malignancy from 2000 to 2022.
Setting:
Single tertiary-care center.
Methods:
Multivariable Cox proportional hazards method was used to examine the relationship between pre-determined clinically important variables and outcomes.
Results:
Five-year overall survival was 77.8% (72.0-84.1). Advanced clinical T stage portended over a 2 times higher risk of death and recurrence. High pathologic grade was associated with a near 3 times higher risk of death and recurrence. There was a predominance of occult nodal metastases in level II for oral cavity and oropharynx site tumors.
Conclusion:
Clinical T stage and grade were important for overall survival, local, regional, and distant recurrence-free survival. Occult nodal metastases occurred most often in level II.
